Sunday, June 26, 2022

Checking in on Immunic Inc. (IMUX) after recent insiders movement

Immunic Inc.’s recently made public that its President and CEO Vitt Daniel acquired Company’s shares for reported $15500.0 on Jun 03. In the deal valued at $3.10 per share,5,000 shares were bought. As a result of this transaction, Vitt Daniel now holds 368,877 shares worth roughly $ 1.37 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Then, Whaley Glenn bought 3,500 shares, generating $10,658 in total proceeds. Upon buying the shares at $3.04, the Chief Financial Officer now owns 12,568 shares.

Before that, Muehler Andreas bought 3,500 shares. Immunic Inc. shares valued at $17,850 were divested by the Chief Medical Officer at a price of $5.10 per share. As a result of the transaction, Muehler Andreas now holds 297,986 shares, worth roughly $1.11 million.

Taking this into account, Aegis Capital initiated its Immunic Inc. [IMUX] rating to a Buy in a research note published on Tuesday, April 15, 2021; the price target was $55. PT values the company’s stock at a premium of 93.24 to its Tuesday closing price. A number of analysts have revised their coverage, including JMP Securities’s analysts, who began to cover the stock in late March with a ‘”a Mkt outperform”‘ rating. SVB Leerink began covering IMUX with a “an Outperform” recommendation on October 02, 2020. Piper Sandler started covering the stock on August 26, 2020. It rated IMUX as “an Overweight”.

Price Performance Review of IMUX

On Tuesday, Immunic Inc. [NASDAQ:IMUX] saw its stock jump 3.62% to $3.72. On the same session, the stock had its day’s lowest price of $3.515, but rose to a high of $3.90. Over the last five days, the stock has gained 18.85%. Immunic Inc. shares have fallen nearly -61.13% since the year began. Nevertheless, the stocks have fallen -70.31% over the past one year. While a 52-week high of $14.50 was reached on 02/10/22, a 52-week low of $2.52 was recorded on 06/02/22. SMA at 50 days reached $6.22, while 200 days put it at $9.22. A total of 0.55 million shares were traded, compared to the trading of 0.46 million shares in the previous session.

Levels Of Support And Resistance For IMUX Stock

The 24-hour chart illustrates a support level at 3.52, which if violated will result in even more drops to 3.33. On the upside, there is a resistance level at 3.91. A further resistance level may holdings at 4.10. The Relative Strength Index (RSI) on the 14-day chart is 37.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.83%. Stochastics %K at 29.25% indicates the stock is a holding.

Immunic Inc. [IMUX] – Who Are The Largest Shareholders?

In filings from RTW Investments LP, it is revealed that the company now owns 2,705,513 shares, or roughly 8.86% of the outstanding IMUX shares. In other words, the investor’s shares have risen by 990,043 from its previous 13-F filing of 1715470.0. Additionally, Cowen & Co. LLC increased 391.35% of its stake after which the total value it holdings stand at $7,794,305, while BlackRock Fund Advisors added 0.48% of its stake to hold $7.46 million in the firm. Over the last quarter, Parkman Healthcare Partners LLC purchased 115,068 shares of Immunic Inc., while The Vanguard Group, Inc. bought 57,885 shares. At present, Commodore Capital LP is holding 893,013 shares valued at $5.54 million. Point72 Asset Management LP owned 725,504 shares of the company at the time of its most recent 13F filing, worth $4.5 million.

According to FactSet, Immunic Inc.’s share price will average $24.60 in the next year, based on opinions of analysts polled by the firm. This is up nearly 484.96 percent from its previous closing price of $3.59. Analysts expect Immunic Inc. stock to reach the higher price of $40.00, while the lowest price estimate is $9.00. However, 5 analysts have rated IMUX stock as a Buy in their predictions for 2022.

Latest news

Related news


Please enter your comment!
Please enter your name here




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam